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Traumatic brain injury (TBI) can occur at any age, from youth to the elderly, and
its contribution to age-related neuropathology remains unknown. Few studies have
investigated the relationship between age-at-injury and pathophysiology at a discrete
biological age. In this study, we report the immunohistochemical analysis of naïve rat
brains compared to those subjected to diffuse TBI by midline fluid percussion injury
(mFPI) at post-natal day (PND) 17, PND35, 2-, 4-, or 6-months of age. All brains
were collected when rats were 10-months of age (n = 6–7/group). Generalized linear
mixed models were fitted to analyze binomial proportion and count data with R Studio.
Amyloid precursor protein (APP) and neurofilament (SMI34, SMI32) neuronal pathology
were counted in the corpus callosum (CC) and primary sensory barrel field (S1BF).
Phosphorylated TAR DNA-binding protein 43 (pTDP-43) neuropathology was counted
in the S1BF and hippocampus. There was a significantly greater extent of APP and
SMI34 axonal pathology and pTDP-43 neuropathology following a TBI compared with
naïves regardless of brain region or age-at-injury. However, age-at-injury did determine
the extent of dendritic neurofilament (SMI32) pathology in the CC and S1BF where
all brain-injured rats exhibited a greater extent of pathology compared with naïve.
No significant differences were detected in the extent of astrocyte activation between
brain-injured and naïve rats. Microglia counts were conducted in the S1BF, hippocampus,
ventral posteromedial (VPM) nucleus, zona incerta, and posterior hypothalamic nucleus.
There was a significantly greater proportion of deramifiedmicroglia, regardless of whether
the TBI was recent or remote, but this only occurred in the S1BF and hippocampus. The
proportion of microglia with colocalized CD68 and TREM2 in the S1BF was greater in
all brain-injured rats compared with naïve, regardless of whether the TBI was recent
or remote. Only rats with recent TBI exhibited a greater proportion of CD68-positive
microglia compared with naive in the hippocampus and posterior hypothalamic nucleus.
Doust et al. Age-at-Injury Influences Neuropathology
Whilst, only rats with a remote brain-injury displayed a greater proportion of microglia
colocalized with TREM2 in the hippocampus. Thus, chronic alterations in neuronal and
microglial characteristics are evident in the injured brain despite the recency of a diffuse
brain injury.
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INTRODUCTION
Traumatic brain injury (TBI) is a neurological condition
that commonly leads to long-term functional deficits such as
impaired memory, cognition, and sensorimotor function (1).
In conjunction with long-term functional deficits, TBI has also
been associated with an increased risk of the development
of neurodegenerative diseases such as Alzheimer’s disease,
chronic traumatic encephalopathy (CTE), multiple sclerosis, and
Parkinson’s disease (2). This chronic presentation of symptoms
and increased risk of neurodegenerative disease may be a result of
TBI-induced cascades that manifest as enduring neuronal injury
and inflammation, as observed both clinically and experimentally
(3–5). Worldwide, the rate of TBI is high, wherein a recent meta-
analysis indicated the highest incidence to be in Australasia,
at an estimated 415 in every 100,000 people (6). Across the
lifespan, TBI is most prevalent in early-life due to domestic
violence/child abuse and falls (7–10), with secondary peaks in
adolescence and aged individuals attributed to increased risk-
taking behaviors (i.e., driving) and falls, respectively (7). Due to
the high prevalence of 18- to 25-year-old male individuals that
sustain a TBI (7), clinical and experimental research has focused
on the behavioral and neuropathological outcomes in young
adult males. There is cumulative research in humans and various
animal models that demonstrate a TBI at any age can result in
long-term sensorimotor, cognitive, and endocrine symptoms in
addition to neuropathology and glial activation, but it remains
unclear whether age-at-injury affects these outcomes (11–16).
An explanation for the extent of TBI neuropathology with
respect to age-at-injury may involve glial changes (17). Glia
exhibit an altered function with aging and, thus, may influence
the TBI neuropathology to a different extent based on the stage
of development when the injury is delivered. Microglia and
astrocytes become dysfunctional with age, which results in an
increased pro-inflammatory profile as well as loss of homeostatic
functions (18–21). This dysfunctional aged phenotype of glia may
promote the vulnerability of neuronal injury as well as modify the
magnitude and duration of the inflammatory response (22).
Competing theories exist for when the brain is most
vulnerable to TBI, as the immature brain is more neuroplastic
than the adult and aged brain. Meaning the immature brain
may have greater capacity for self-repair after an injury and,
hence, minimal functional impairment (23). On the contrary,
underdevelopment of the young brain may increase vulnerability
to long-term deficits after a brain injury, because of a potential
interruption of critical developmental processes (24, 25). With
regard to the aging brain, tissue properties (e.g., stiffness,
atrophy) may impart susceptibility to damage after a TBI,
which can worsen functional outcomes in comparison to
injury in juveniles and adults (26, 27). More research is
required to better understand the relationship between age and
enduring pathology from a TBI which might inform possible
therapeutic intervention.
In our prior work in rats, age-at-injury was associated with
persistent motor deficits on the beam walk, anxiety-like behavior
in the open field, and spatial memory deficits with novel objects
(28). Here, we investigated whether neuropathology, in those
same animals, was related to the recency (2-, 4-, 6-months
of age-at-injury) or remoteness (17- or 35-days old at injury;
PND17, PND35) of a TBI, where neuropathology was inclusive
of neuronal, astroglial, and microglial changes. We hypothesized
that neuropathology and gliosis is evident after a diffuse TBI and
the extent of pathology is determined by age-at-injury.
METHODS
Experimental Design, Injury Induction, and
Tissue Collection
Male Sprague-Dawley rats (Harlan Laboratories, Inc.,
Indianapolis, Ind., USA) were received as a single shipment
at post-natal day (PND) 10, with the dam, and acclimated for
7-days prior to experimentation. This report is part of a larger
study where rats (n = 81) were assigned to age-at-injury groups
upon arrival. Rats underwent behavioral assessments following
TBI with results being previously published (28). A midline fluid
percussion injury (mFPI) was used to experimentally produce
a diffuse TBI at juvenile (PND17), adolescent (PND35), young
adult (2-months-old), or mature adult (4- and 6-months-old)
ages compared to naïve rats. Group allocation, injury induction,
and housing have been previously described (28). Briefly, rats
were anesthetized with isoflurane (5% mixed with 100% O2 at
1 L/min) for 5min and the head was secured in a stereotaxic
frame via the ear and bite bars. Anesthesia and body temperature
were maintained throughout the surgery by a nosecone (2.5%
isoflurane mixed with 100% O2 at 0.4 L/min) and a Deltaphase
isothermal heating pad, respectively. A midline incision was
made from between the eyes to just behind the ears with the
fascia scraped from the skull. Various sizes of trephines were
used based on the ratio of the size of the craniotomy to the
size of the skull [3.0mm (PND 17), 4.0mm (PND35), 4.8mm
(2-, 4-, 6-months) (29)] to remove a circular piece of the skull
on the sagittal suture, half-way between bregma and lambda,
with the dura remaining intact. The female Luer-Loc injury hub
was cut from a needle and secured over the craniotomy site
using cyanoacrylate gel followed by methyl-methacrylate. The
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posterior and anterior edges of the incision were closed and
topical Lidocaine ointment applied to the area. Rats were placed
in a recovery cage warmed upon a heating pad and monitored
until ambulatory.
After 60–90min of recovery, rats were re-anesthetized with
isoflurane (5% mixed with 100% O2 at 1 L/min) for 5min
in preparation for injury induction. The hub and dura were
visually inspected for obstructions or blood and then filled with
saline. The female Luer-Loc on the rats was connected to the
male Luer-Loc on the fluid percussion injury device; PND17
rats were connected using a Luer-Loc extension tube. Traumatic
brain injury was induced by releasing the pendulum onto the
fluid-filled cylinder, producing a pressure pulse (atmospheres)
depending on age and body-weight: 1.5 atm (PND17), 1.9 atm
(PND35), 2.1 atm (2-months), 2.2 atm (4-months), 2.7 atm (6-
months). The time, post-injury, before the rats regained the
righting reflex, as well as the duration of apnea and seizures,
were recorded. The righting reflex times in this study ranged
between 5 and 10min, which represents an injury with known
acute motor deficits. Once righted, the rats were re-anesthetized
with isoflurane (5% mixed with 100% O2 at 1 L/min) for 5min
and the injury hub was removed. Before closing the incision,
the wound was cleaned with saline and the craniotomy site and
underlying dura were inspected for hematoma, herniation, and
dural breach.
Rats recovered in warmed cages until ambulatory (approx.
5 and 15min) before being returned to the dam (PND17)
or home cage and the cage placed back in the colony. Post-
surgical evaluations were conducted on the rats daily for 3
days via physical examination of behavior, appearance, suture-
or staple-site, and weight as well as for any signs of pain or
distress. The weight of all rats was recorded weekly for 10-
months; no statistical differences in weight were noted (28).
Appropriate measures were taken to minimize animal pain and
distress associated with surgery and brain injury. All animal care
and experimental procedures were approved by the Institutional
Animal Care and Use Committees (IACUC) at the University of
Arizona (Phoenix, AZ, USA) and conducted in accordance with
the Association for Assessment and Accreditation of Laboratory
Animal Care International and NIH guidelines. This research is
reported according to the ARRIVE (Animal Research: Reporting
in vivo Experiments) guidelines. Twelve rats were excluded from
the study entirely: (1) one rat developed an epithelial tumor; (2)
one rat aspirated after the forced swim behavioral task; (3) one rat
was incorrectly sexed during initial screening upon arrival and
was, thus, removed along with its cage mate;(4) two 6 month rats
died after injury; (5) five rats were excluded as surgical failures.
Each rat was housed with another rat assigned to a different
injury group, such that cage mates did not receive an injury at the
same time. Injury groups were assigned prior to experimentation
in order to achieve randomization. Power calculations were
conducted to determine sample size for adequate detection of
injury-induced pathology whilst minimizing animal numbers.
A battery of behavior tests was conducted on these animals at
1.5-, 3-, 5-, 7-, and 10-months of age to assess vestibulomotor
function, spatial memory, anxiety, and depressive-like behavior,
as previously described [(28); Supplementary Figure 1]. Tissue
was collected at 10-months of age where rats were transcardially
perfused with 10% formalin (Millipore Sigma, USA). The brain
remained in situ for approximately 1 h before being dissected
from the cranium and drop-fixed in 10% formalin overnight,
then transferred into 0.02% sodium azide (NaN3) in phosphate
buffered saline (PBS). Brains (n = 36; naïve, n = 5; PND17,
n = 6; PND35, n = 7; 2 months, n = 6; 4 months, n = 6;
6 months, n = 6) were shipped to the University of Tasmania
(Hobart, Tasmania, Australia) for sectioning and tissue analysis
(Supplementary Figure 1). Brains were sectioned in the coronal
plane at 40µm on a vibratome and tissue was collected in a
24-well plate and stored at 4◦C in PBS with 0.02% sodium
azide prior to performing immunohistochemistry. During the
immunohistochemical analyses, the investigator was blinded to
the age-at-injury group of the sample.
Immunohistochemical Staining for
Neuropathology and Glial Activation
Nickel-Enhanced 3,3-Diaminobenzidine
Immunohistochemistry of Neuropathological Profiles
and Astrogliosis
Three sections per brain were stained with APP, SMI32, SMI34,
and Phosphorylated TAR DNA-binding protein 43 (pTDP-43)
for neuronal pathology (approximate location anterior/posterior
to Bregma: −0.37, −2.26, −4.38mm) and Glial fibrillary
acidic protein (GFAP) immunoreactivity (approximate location
anterior/posterior to Bregma: −3.68, −4.03, −4.38mm). Tissue
sections were washed in PBS with 0.01% tween-20 (PBST)
then placed in a blocking solution for 90min (see Table 1).
Sections were incubated with the primary antibody diluted in
1% block solution overnight at 4◦C (see Table 1). Sections
were washed in PBST and incubated in the corresponding
biotinylated secondary antibody diluted in blocking solution for
1 h (see Table 2). After washing, sections were placed in 3%
hydrogen peroxide for 10min. Sections were rinsed and placed
in Avidin-Biotin Complex (ABC, Vector) for 30min. Tissue was
washed a final time in PBST and placed in nickel-enhanced 3,3-
diaminobenzidine (DAB) (Vector, cat no. SK4100) for 5min then
transferred to a plate of tap water. Sections were mounted on
glass slides (Dako, Denmark) and left to air-dry (∼30min) before
being dehydrated in graded ethanol, cleared in xylene, and cover
slipped with DePeX. For each staining run, a negative control (no
primary antibody) was included. For each stain all sections from
each animal were stained in one batch to prevent variation.
Sections incubated with rabbit anti-TDP-43 phosphorylated
s409/410 (pTDP-43) required citric acid buffer (pH 4.0) antigen
retrieval for 20min at 80◦C and left to cool to room temperature
(RT) prior to being placed in blocking solution. These sections
were counterstained with nuclear fast red (70% ethanol for 5min,
nuclear fast red for 10min and tap water for 2min) prior to
dehydration with ethanol. Slides were then cleared in xylene and
cover slipped with DePex mounting medium (Dako, Denmark)
using the Dako automated cover slipper (Dako, Denmark).
Double Labeling of Microglia and Phenotypic Markers
Two sections per brain (approximate location anterior/posterior
to Bregma: −2.26, −4.38mm) were stained for microglia and
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TABLE 1 | Antibody and blocking solution information used when conducting nickel-enhanced 3,3-diaminobenzidine (DAB) and fluorescent-labeling
immunohistochemistry.
















































R and D Systems,
cat no. AF1729
1:500 PBS 4% NGS
in PBS
PBST, PBS + 0.01% tween-20; TX-100, TritonX-100; NHS, normal horse serum; NGS, normal goat serum.
TABLE 2 | Secondary antibody information used when conducting
nickel-enhanced 3,3-diaminobenzidine (DAB) and fluorescent-labeling
immunohistochemistry.


























colocalization with functional markers. Tissue sections, adjacent
to those stained with DAB, were washed in PBS and placed in
a blocking solution of 4% normal goat serum (NGS) in PBS for
90min. Sections were then incubated in the primary antibody
diluted in 1% block solution overnight at 4◦C (see Table 1). After
being washed in PBS, the tissue was incubated in secondary
antibodies for 1 h (see Table 2). Followed by a final wash in PBS,
the sections were then mounted on slides and cover slipped with
fluoromount fluorescent mounting medium (Dako, Denmark).
Slides were stored at 4◦C shielded from light until fluorescent
confocal microscopy. Negative controls were included in each
run to ensure there was no cross-reactivity of antibodies.
Image Acquisition and Data Analyses
Regions of Interest Selected for Analyses of
Neuropathological Profiles and Glial Response
The white matter of the corpus callosum (CC) is known to
harbor neuronal pathology after a TBI as the angle of axons
entering the CCmake them particularly vulnerable to injury (30).
Neuronal injury is also reported in the primary sensory barrel
field (S1BF), which is associated with sensory deficits that are
commonly described after a TBI (31–33). The cingulate cortex
connects to the hippocampus, which, together, form the majority
of the memory circuitry (34). The periventricular white matter
that surrounds the lateral ventricle is associated with the sensory
circuitry (35). The dorsolateral entorhinal cortex is also involved
with the sensory and memory circuitry (36, 37). The zona incerta
is a subthalamic nucleus that connects many brain regions,
including the sensory- and memory-related structures which
are regularly reported to exhibit functional impairments and
neuropathology after a TBI (38–40). The ventral posteromedial
nucleus (VPM) is part of the thalamus, that, in conjunction with
the zona incerta, connects with many brain regions, such as the
S1BF and hippocampus (41, 42). The posterior hypothalamic
nucleus is also involved with the sensory and memory circuitry,
including specific glial roles in regulating metabolism (43), which
is known to be affected post-injury as a result of endocrine
dysfunction (43–45).
Bregma levels (approximate location anterior/posterior
to Bregma: −0.37, −2.26, −4.38mm) stained for neuronal
pathology contained the CC, S1BF, and hippocampus. Bregma
levels (approximate location anterior/posterior to Bregma:
−3.68, −4.03, −4.38mm) stained for GFAP contained the S1BF,
hippocampus, cingulate cortex, periventricular white matter,
dorsolateral entorhinal cortex, and zona incerta. Finally, bregma
levels examined for microglial activation (approximate location
anterior/posterior to Bregma: −2.26, −4.38) contained the
S1BF, hippocampus, VPM, and posterior hypothalamic nucleus.
The only regions investigated for amyloid precursor protein
(APP) and neurofilament neuronal pathology (SMI34, SMI32)
were the CC and S1BF. As pTDP-43 neuronal proteopathy
occurs in the perikarya and proximal axon, pTDP-43 was
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examined in cell bodies of the S1BF and hippocampus. Astrocyte
and microglial activation were also investigated in regions
of neuronal pathology (S1BF, hippocampus). When neurons
become damaged, communication between brain regions can be
compromised, without overt neuronal pathology, but evident
in glial changes (46). As such, the connecting regions examined
for astrocyte activation were the cingulate cortex, periventricular
white matter, dorsolateral entorhinal cortex, and zona incerta.
For microglia activation, the connecting structures were the
zona incerta, VPM, and posterior hypothalamic nucleus.
Neuronal pathology was not quantified in the cingulate cortex,
periventricular white matter, dorsolateral entorhinal cortex,
zona incerta, and VPM as there was no overt pathology in these
regions (Supplementary Figure 2).
Brightfield and Confocal Microscopy of Coronal
Tissue Sections Stained for Neuropathology and Glia
Photomicrographs of DAB-stained tissue were taken using
the ZEISS Axio Lab.A1 with an attached 6-megapixel ZEISS
Axiocam 506 color camera using the 20x/0.4 objectives (ZEISS,
Germany). For fluorescent-stained tissue, z-stack images (1
image taken per 1µm of optical thickness) were captured via
the Volocity 6.3 software using the Perkin-Elmer UltraVIEW
VoX system, involving an inverted Ti Eclipse microscope
(Nikon, Japan) with a CSU-X1 spinning disk confocal scanner
(Yokogawa Electric Corporation, Japan), plan apochromatic
20x/0.75 objective (Nikon, Japan), and excitation lasers/emission
filters of wavelength 488/525 and 561/615.
Segmentation of GFAP-Labeled Astrocytes
One image was taken per region of interest (ROI) per
hemisphere from three sections per animal to yield six
images per animal per ROI which were analyzed for GFAP-
labeled astrocytes. Images were converted from TIFFs to 8-
bit TIFFs for segmentation, using the Fiji plugin, imageSURF
(47). Segmentation distinguishes the positive staining from
the background that were quantified to yield the number of
GFAP-positive pixels per image. The number of GFAP-positive
(GFAP+) pixels in each image is expressed as the number
GFAP+ pixels/mm2 which is averaged across each group with
95% confidence intervals (CI).
Manual Counts of Neuropathological Profiles and
Microglial Phenotypes
For counts of APP, SMI32, SMI34, and pTDP-43 neuronal
pathology, one image was taken per ROI per hemisphere from
three sections per animal to yield six images per animal per
ROI. The number of neuropathological profiles were counted in
each image and expressed as the number of neuropathological
profiles/mm2 which is averaged across each group with 95% CI.
In order to count microglial morphologies and colocalization
with functional markers, one image was taken per hemisphere
from two sections per animal to yield four images per animal per
ROI. A 1 mm2 grid was placed across the image and all microglia
FIGURE 1 | APP neuronal profiles were quantified in the CC and S1BF. Indicative images of neuronal pathology visualized by APP immunohistochemistry were taken
in the primary sensory barrel field (S1BF) of rats brain-injured at 6-months of age. Quantitative analysis included bulbs (A), blebbing (B), and cell bodies (C) indicated
by the black arrows (scale bar = 50µm). Counts of neuronal pathology are expressed as the number of APP-positive (APP+) profiles/mm2 (mean ± 95%CI) in the
corpus callosum (CC) and S1BF. Significantly more APP+ profiles were observed following mFPI, regardless of age-at-injury, compared to naïves in both the CC (D)
and the S1BF (E).
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within every other square counted, with a target of 100 microglia,
using the cell counter tool; similar to our previously published
work (48). The total number of microglia and the number
of deramified microglia were summed for all four images per
animal. The number of deramified microglia was then divided
by the total number of microglia cells to yield a proportion of
deramified microglia out of the total number of cells counted
in all four images. The proportion of deramified microglia per
animal was then averaged across each group with 95% CI. The
proportion of microglia colocalized with functional markers
(CD68, TREM2) was calculated by counting the total number
of microglia and the number of microglia colocalized with either
CD68 or TREM2. The number of colocalized microglia was then
divided by the total number of microglia to yield a proportion of
colocalized microglia out of the total number of cells counted.
The proportion of colocalized microglia per animal was then
averaged across each group with 95% CI.
Statistical Analysis
The binomial proportion of total cells (microglia) that were
deramified or colocalized with CD68 or TREM2 was estimated
using logistic regression in a generalized linear mixed effects
model. Cell counts were made within the S1BF, hippocampus,
VPM nucleus, zona incerta, and posterior hypothalamic nucleus,
so a random intercept was fitted for each animal to account for
this clustering in the data. We used the “lme4” package (49) in
the R statistical (50) computing environment.
Counts of APP, SMI34, and SMI32 neuropathology were
conducted in the CC and S1BF. Counts of pTDP-43 pathology
were performed in the S1BF and hippocampus. Counts of
FIGURE 2 | SMI34 axonal profiles were quantified in the CC and S1BF. Indicative images of healthy axons (A) and axonal pathology visualized by SMI34
immunohistochemistry were taken in the primary sensory barrel field (S1BF) of rats brain-injured at 6-months of age. Analysis quantified bulbs (B), blebbing (C),
thickened axons (white arrows; D) or undulated axons (black arrows; D), thickened and undulated axons (E), corkscrews (F), and rings (G) indicated by the arrows
(scale bar = 50µm, inset = 10µm). Counts of axonal pathology are expressed as the number of SMI34+ profiles/mm2 (mean ± 95%CI) in the corpus callosum (CC)
and S1BF. There were significantly more SMI34-positive (SMI34+) profiles observed post-injury, regardless of age-at-injury, compared to naïves in both the CC (H) and
the S1BF (I).
Frontiers in Neurology | www.frontiersin.org 6 September 2021 | Volume 12 | Article 722526
Doust et al. Age-at-Injury Influences Neuropathology
FIGURE 3 | SMI32 dendritic profiles were quantified in the CC and S1BF. Indicative images of healthy dendrites (A) and dendritic pathology visualized by SMI32
immunohistochemistry were taken in the primary sensory barrel field (S1BF) of rats brain-injured at 6-months of age. Quantitative analysis included bulbs (B), blebbing
(C), thickened axons (white arrows; D), or undulated axons (black arrows; D), thickened and undulated axons (E), corkscrews (F), and rings (G) indicated by the
arrows (scale bar = 50µm, inset = 10µm). Dendritic pathology was expressed as the number of SMI32+ profiles/mm2 (mean ± 95%CI) in the corpus callosum (CC)
and S1BF. Significantly more SMI32+ profiles were observed following mFPI compared to naïves in the CC (H), regardless of whether the TBI was recent or remote.
However, a greater extent of SMI32 pathology in the S1BF (I) compared with naïves was only evident with a more recent TBI (see Table 3).
TABLE 3 | SMI32 post-hoc contrasts between age-at-injury groups and naïve controls, separated by region, using the Dunnett’s procedure.
Contrast:
age-at-injury (Dunnett)
Region Co-efficient estimate Lower 95% CI Upper 95% CI p-values
N vs. PND17 CC 0.5800 0.0483 1.112 0.0326
N vs. PND35 CC 0.8610 0.3574 1.364 0.0009
N vs. 2-months CC 1.1000 0.5974 1.602 <0.0001
N vs. 4-months CC 0.8890 0.3852 1.392 0.0006
N vs. 6-months CC 1.1720 0.6737 1.670 <0.0001
N vs. PND17 S1BF 0.4200 −0.0249 0.865 0.0642
N vs. PND35 S1BF 0.3290 −0.0966 0.755 0.1293
N vs. 2-months S1BF 0.5980 0.1725 1.023 0.006
N vs. 4-months S1BF 0.5660 0.1419 0.991 0.0091
N vs. 6-months S1BF 0.5400 0.1151 0.964 0.0129
Bold means statistically significant p < 0.05.
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GFAP-positive pixels were conducted in the S1BF, hippocampus,
cingulate cortex, periventricular white matter, dorsolateral
entorhinal cortex, and zona incerta. For count data we fitted
generalized linear mixed effects models with random intercepts
to account for clustering in the data, but used the “glmmTMB” R
package (51) so that we could assess different error distributions.
We fitted Poisson and negative binomial models (linear and
quadratic parameterizations) and selected the best model using
Aikake’s information criterion (52). Consequently, we fitted
negative binomial models (quadratic parameterization) for APP,
SMI34, SMI32, and pTDP-43 counts; whilst we fitted Poisson
models (linear parameterization) for counts of GFAP+ pixels.
For numerical stability of pTDP-43 counts we added 1 to all
counts and used a log link function, since the naïve controls
expressed no TDP43. An alternative was to fit a Gaussian model,
but this mode underestimated standard errors and gave poor
coverage of CI.
Likelihood ratio tests were used to compute p-values.
Estimatedmarginal means and post-hoc contrasts were computed
with the “emmeans” R package (53), with corrections for
multiple comparisons to appropriately control Type 1 errors
using Dunnett’s method.
RESULTS
This study investigated whether age-at-injury influenced
neuropathology and glial activation at 10-months of age in male
rats. For this, 36 male rats were either subjected to a single
diffuse TBI at PND17, PND35, 2-, 4-, or 6-months of age or
allowed to age in the naïve state. At 10-months of age, all rats
were prepared for brain immunohistochemical studies reported
here. Neurobehavioral outcomes in these rats have been reported
elsewhere (28).
The Extent of APP Axonal Pathology Was
Greater in Brain-Injured Groups Compared
With Naïve in the CC and S1BF, Regardless
of Whether the TBI Was Recent or Remote
A hallmark of TBI is the accumulation of APP within
neuronal axons and somas (5, 54). Visualization of this axonal
transport disruption in the CC and S1BF was achieved via APP
immunohistochemistry. Pathological profiles were defined as
bulbs, blebbing, or cell bodies which are depicted in the S1BF
(Figures 1A–C). The number of APP-positive (APP+) profiles
were quantified in each image taken of the CC and S1BF per mm2
FIGURE 4 | pTDP-43 neuronal profiles were quantified in the S1BF and hippocampus. Indicative images of neuronal pathology visualized by pTDP-43
immunohistochemistry were taken in the primary sensory barrel field (S1BF) of rats injured at 6-months of age. Quantitative analysis included nuclei inclusions (A) and
cytoplasmic neurites (B) indicated by the black arrows (scale bar = 50µm). Counts of neuronal pathology are expressed as the number of pTDP-43+ profiles/mm2
(mean ± 95%CI) in the S1BF and hippocampus. Significantly more pTDP-43+ profiles were observed following mFPI, regardless of age-at-injury, compared to naïves
in both the S1BF (C) and the hippocampus (D).
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(Figures 1D,E). Animals in the injured groups had significantly
more APP+ profiles than naïve controls (χ25 = 70.7; p < 0.001),
but APP+ profiles in age-at-injury groups varied significantly by
region (χ25 = 29.8; p < 0.001) (see Supplementary Table 1 for
estimated counts and their 95% CIs; illustrated in Figures 1D,E).
These quantitative data demonstrate that neuropathology is
evident after a single TBI, regardless of whether the TBI was
recent or remote.
The Extent of SMI34 Neurofilament
Pathology Was Greater in Brain-Injured
Groups Compared With Naïve in the CC
and S1BF, Regardless of Whether the TBI
Was Recent or Remote
Axonal pathology was assessed via changes to the axonal
cytoskeleton, particularly the neurofilament network which
provides the axon with caliber and integrity (55, 56).
Immunohistochemistry against phosphorylated neurofilament
heavy chain (SMI34) was used to visualize cytoskeletal axonal
changes in the CC and S1BF. SMI34 staining in healthy axons
of naïve brain appears as thin and straight fibers in the S1BF
(Figure 2A), and in response to brain injury, the cytoskeleton
and axon exhibit bulbs, blebbing, thickening, undulations,
corkscrews, and rings (Figures 2B–G). Cytoskeletal changes
were quantified in each image taken as the number of SMI34-
positive (SMI34+) profiles per mm2 in both the CC and S1BF
(Figures 2H,I). Animals in the injured groups had significantly
more SMI34+ profiles than naïve controls (χ25 = 24.0; p< 0.001),
but SMI34+ profiles in age-at-injury groups varied significantly
by region (χ25 = 16.4; p < 0.01) (see Supplementary Table 2 for
estimated counts and 95% CIs; also illustrated in Figures 2H,I).
These quantitative data demonstrate that neurofilament axonal
pathology is present after a TBI, regardless of age-at-injury.
The Extent of SMI32 Neurofilament
Pathology Was Greater in Brain-Injured
Groups Compared With Naïve in the CC,
Regardless of Whether the TBI Was Recent
or Remote, but Was Determined by
Age-at-Injury in the S1BF
To further examine cytoskeletal changes after TBI,
immunohistochemistry against non-phosphorylated
neurofilament heavy chain (SMI32) was used to identify
dendritic neuronal pathology in the CC and S1BF. SMI32
immunoreactivity in healthy neurons of naïve brain appears as
thin, straight fibers in dendrites with a slender outline around
the perikarya in the S1BF (Figure 3A). Following brain-injury,
SMI32 staining of pathology appeared as bulbs, blebbing,
thickened, undulated as well as thickened and undulated
dendrites, corkscrews, and rings in the S1BF (Figures 3B–G).
Dendritic pathology was quantified in each image taken as the
number of SMI32-positive (SMI32+) profiles per mm2 that
occurred in both the CC and S1BF (Figures 3H,I). Animals in
the injured groups had significantly more SMI32+ profiles than
naïve (χ25 = 13.3; p < 0.05), but SMI32+ profiles in age-at-injury
groups varied significantly by region (χ25 = 24.6; p < 0.001)
(see Supplementary Table 3 for estimated counts and 95% CIs;
Figures 3H,I). In the CC, brain-injured groups exhibited a
significantly greater extent of SMI32+ profiles/mm2 compared
with naïve (see Table 3). However, in the S1BF, only rats injured
at 2-, 4-, and 6-months of age (recent brain injury) displayed a
significantly greater extent of SMI32+ profiles/mm2 compared
with naïve (see Table 3). These quantitative data implicate
neurofilament dendritic pathology is apparent after a TBI, where
the extent of pathology in gray matter of the S1BF is only greater
than naïve controls with a more recent injury.
The Extent of pTDP43 Neuronal Pathology
Was Greater in Brain-Injured Groups
Compared With Naïve in the S1BF and
Hippocampus, Regardless of Whether the
TBI Was Recent or Remote
TAR DNA-binding protein 43 (TDP-43, transactive response
DNA binding protein 43 kDa) primarily resides in the nucleus
where it acts as a transcription factor and presents diffusely in the
cytoplasm of the perikarya which is proposed to be involved with
mRNA splicing and stability (57). The TDP-43 protein is known
to become hyper-phosphorylated in pathological conditions,
such as after a TBI, and aggregate within the nucleus of neurons,
or translocate into the cytoplasm (58, 59). It is unclear how
aggregated TDP-43 damages neurons other than reducing its
functions in the nucleus (57). However, it is known that TDP-
43 aggregation is detrimental to neurons as it is a hallmark of a
number of neurodegenerative diseases including frontotemporal
lobar dementia (FTLD) and amyotrophic lateral sclerosis (ALS)
(60, 61). Immunohistochemistry against phosphorylated TDP-
43 (pTDP-43) was conducted in order to visualize TDP-43
neuronal pathology in the S1BF and hippocampus. In the S1BF,
pTDP-43+ profiles were identified as nuclei inclusions and
cytoplasmic neurites (Figures 4A,B). Proteopathy of TDP-43
was quantified in each image as the number of phosphorylated
TDP-43-positive (pTDP-43+) profiles per mm2 in the S1BF
and hippocampus (Figures 4C,D). Brain-injured animals had
significantly more pTDP-43+ profiles than naïve (χ25 = 149.2;
p < 0.001) where pTDP-43+ profiles in age-at-injury groups
did not significantly vary by region (χ25 = 7.6; p = 0.1788)
(see Supplementary Table 4 for estimated counts and 95%
CIs; see Figures 4C,D). The results indicate that TDP-43 is
hyperphosphorylated in the S1BF and hippocampus, as detected
in the nucleus and cytoplasm, after a single diffuse TBI regardless
of whether the TBI was recent or remote. To examine whether
age-at-injury influences further downstream aspects of the
TBI molecular cascade, immunohistochemical analysis of glial
activation was explored.
No Differences in the Extent of GFAP
Expressed by Astrocytes Was Evident
Between Brain-Injured and Naïve Groups,
Regardless of Whether the TBI Was Recent
or Remote
Glial fibrillary acidic protein is a structural protein present
in astrocytes. In the S1BF, astrocytes typically appear in
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FIGURE 5 | GFAP immunoreactivity was quantified in the S1BF, hippocampus, cingulate cortex, periventricular white matter, dorsolateral entorhinal cortex, and zona
incerta. Representative images of ramified (A) and hypertrophic (B) astrocytes, indicated with black arrows (scale bar = 50µm), visualized by GFAP
immunohistochemistry were taken in the primary sensory barrel field (S1BF) of rats injured at 6-months of age. The expression of GFAP increases when astrocytes
become hypertrophic and, thus, activated. Therefore, the extent of GFAP immunoreactivity is used as a measure of astrocyte activation and is expressed as the
number of GFAP-positive pixels/mm2 (mean ± 95%CI) in the S1BF, hippocampus, cingulate cortex, lateral ventricle, dorsolateral entorhinal cortex, and zona incerta.
There were no significant differences in the percentage of GFAP+ profiles observed following mFPI, regardless of age-at-injury, compared to naïves in the S1BF (C),
hippocampus (D), cingulate cortex (E), periventricular white matter (F), dorsolateral entorhinal cortex (G), or the zona incerta (H).
the healthy brain as star-shaped cells with fine and highly
ramified processes [Figure 5A; (62)]. After an insult, astrocytes
become activated, which involves hypertrophy with an enlarged
perikarya, reduced process complexity, and increased expression
of GFAP [Figure 5B; (62)]. Thus, the extent of GFAP expressed
by astrocytes is used as a measure of astrocyte activation
following injury. The extent of GFAP expressed by astrocytes
was quantified in each image taken of the S1BF, hippocampus,
cingulate cortex, lateral ventricle, dorsolateral entorhinal cortex,
and zona incerta as the number of GFAP+ pixels per mm2
(Figures 5C–H). Animals in the injured groups showed no
significant differences in GFAP immunoreactivity compared with
naïve (χ25 = 8.4; p = 0.1374). Glial fibrillary acidic protein
immunoreactivity was different between brain regions analyzed,
for example S1BF compared to hippocampus. However, there was
no effect of injury on these differences (χ225 = 50.5; p < 0.01)
(see Supplementary Table 5 for estimated counts and 95% CIs;
Figures 5C–H). These quantitative data demonstrate that the
expression of GFAP by astrocytes is comparable to naïve at 4–9.5
months after injury. The current study cannot determine whether
temporal changes in GFAP occurred post-injury as reported by
others (63).
The Proportion of Deramified Microglia
Was Greater in Brain-Injured Groups
Compared With Naïve in the S1BF and
Hippocampus, Regardless of Whether the
TBI Was Recent or Remote
Ionized calcium binding adaptor molecule 1 (Iba1) is an actin-
binding protein that is present in the microglial cytoskeleton
and can be used to visualize microglia morphology (64). In
the S1BF, microglia in the healthy brain typically appear in
a ramified morphology with a small, round somata and long,
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FIGURE 6 | The proportion of deramified microglia were quantified in the S1BF, hippocampus, VPM, zona incerta, and posterior hypothalamic nucleus.
Representative images of ramified (A) and deramified (B–E) microglia, indicated by the black arrows (scale bar = 50µm), visualized by Iba1 immunohistochemistry
were taken in the primary sensory barrel field (S1BF) of rats injured at 6-months of age. The proportion of deramified microglia (mean ± 95%CI) was determined in the
S1BF, hippocampus, ventral posteromedial nucleus (VPM), zona incerta, and posterior hypothalamic nucleus. There was a significantly greater proportion of
deramified microglia observed after brain injury, regardless of age-at-injury, compared to naïves in the S1BF (F), hippocampus (G) but not in the zona incerta (H), VPM
(I), or posterior hypothalamic nucleus (J).
thin, and highly branched processes [Figure 6A; (65)]. After an
injury or infection, microglia undergo de-ramification where the
cell body typically becomes swollen, and processes are retracted
with reduced complexity. These morphologies are referred to
as hyper-ramified, hypertrophic, and amoeboid [Figures 6B–D;
(65)]. In addition to this, microglia have also been documented in
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aging and after an injury to have an elongated cell body with short
processes along its length, referred to as rodmicroglia [Figure 6E;
(66)]. Microglia morphologies were quantified in the S1BF,
hippocampus, zone incerta, VPM, and posterior hypothalamic
nucleus as the proportion of deramified microglia in relation
to the total cell count in all four images per ROI per animal
(Figures 6F–J). Animals in the injured groups had significantly
greater proportion of deramifiedmicroglia than naïve (χ25 = 56.1;
p < 0.001), but the proportion of deramified microglia in age-
at-injury groups varied significantly by region (χ220 = 113.9; p <
0.001) (see Supplementary Table 6 for estimated counts and 95%
CIs; Figures 6F–J). In the S1BF and hippocampus, brain-injured
groups exhibited a significantly greater proportion of deramified
microglia compared with naïve (see Table 4). However, in the
VPM, zona incerta, and posterior hypothalamic nucleus, there
were no significant differences in the proportion of deramified
microglia between brain-injured groups compared to naïve (see
Table 4). These quantitative data demonstrate that microglia
become deramified after a single remote TBI, particularly in the
S1BF and hippocampus.
The Proportion of Microglia Colocalized
With CD68 Was Greater for Brain-Injured
Groups in the S1BF, VPM, and Zona
Incerta, Regardless of Whether the TBI
Was Recent or Remote
Variations in the functional activation of microglia have been
classified by the presence of specific immunohistochemical
markers. To explore functional aspects of microglial activation,
dual staining with ionizing actin-binding protein 1 (Iba1) and a
surrogate marker of phagocytosis, cluster of differentiation
68 (CD68), was conducted. Microglia were counted in
the S1BF, hippocampus, VPM, zona incerta, and posterior
hypothalamic nucleus. In the S1BF, ramified microglia were
evenly spread throughout each image taken per ROI and
displayed minimal CD68 immunoreactivity (Figure 7A).
Whilst pockets of hyper-ramified (Figure 7B) and deramified
(Figure 7C) morphologies were observed and identified
as CD68-positive (CD68+). Small numbers of amoeboid
microglia were also present, and intermittently observed to
TABLE 4 | Deramified microglia post-hoc contrasts between age-at-injury groups and naïve controls, separated by region, using the Dunnett’s procedure.
Contrast:
age-at-injury (Dunnett)
Region Co-efficient estimate Lower 95% CI Upper 95% CI p-values
N vs. PND17 S1BF 0.6760 0.4655 0.886 <0.0001
N vs. PND35 S1BF 0.6981 0.5027 0.894 <0.0001
N vs. 2-months S1BF 0.5766 0.3605 0.793 <0.0001
N vs. 4-months S1BF 0.7920 0.6001 0.984 <0.0001
N vs. 6-months S1BF 0.8397 0.6502 1.029 <0.0001
N vs. PND17 Hippocampus 0.9485 0.7132 1.184 <0.0001
N vs. PND35 Hippocampus 0.9736 0.7407 1.207 <0.0001
N vs. 2-months Hippocampus 0.9777 0.7382 1.217 <0.0001
N vs. 4-months Hippocampus 0.9239 0.6814 1.166 <0.0001
N vs. 6-months Hippocampus 0.8646 0.6257 1.103 <0.0001
N vs. PND17 VPM 0.1090 −0.1201 0.338 0.3511
N vs. PND35 VPM 0.0507 −0.1483 0.250 0.6175
N vs. 2-months VPM 0.0926 −0.1247 0.310 0.4036
N vs. 4-months VPM 0.0687 −0.1276 0.265 0.4927
N vs. 6-months VPM 0.0665 −0.1266 0.259 0.4999
N vs. PND17 Zona incerta 0.0732 −0.1515 0.298 0.5232
N vs. PND35 Zona incerta 0.0436 −0.1419 0.229 0.6453
N vs. 2-months Zona incerta 0.0833 −0.1307 0.297 0.4455
N vs. 4-months Zona incerta 0.0913 −0.1122 0.295 0.3790
N vs. 6-months Zona incerta 0.0276 −0.1674 0.223 0.7811
N vs. PND17 Posterior hypothalamic
nucleus
0.1041 −0.0997 0.308 0.3167
N vs. PND35 Posterior hypothalamic
nucleus
0.0515 −0.1216 0.225 0.5600
N vs. 2-months Posterior hypothalamic
nucleus
0.1010 −0.0959 0.298 0.3148
N vs. 4-months Posterior hypothalamic
nucleus
0.0537 −0.1329 0.240 0.5727
N vs. 6-months Posterior hypothalamic
nucleus
0.0192 −0.1670 0.205 0.8397
Bold means statistically significant p < 0.05.
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FIGURE 7 | Examples of microglial morphologies colocalized with CD68 in the S1BF of rats brain-injured at 6-months of age. Representative images of microglial
morphologies were taken in the primary sensory barrel field (S1BF) of rats injured at 6-months of age; ramified (A), hyper-ramified (B), hypertrophic (C), amoeboid (D),
and rod (E), and their colocalization with CD68 indicated with the white arrows (scale bar = 50µm).
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FIGURE 8 | The proportion of microglia colocalized with CD68 were quantified in the S1BF, hippocampus, VPM, zona incerta, and posterior hypothalamic nucleus.
Microglial colocalization with CD68 is expressed as the proportion of CD68+ microglia (mean ± 95%CI) in the primary sensory barrel field (S1BF), hippocampus,
ventral posteromedial nucleus (VPM), zona incerta, and posterior hypothalamic nucleus. Significantly more CD68+ microglia were observed following mFPI compared
to naïves in the S1BF (A), zona incerta (C), and VPM (D) regardless of whether the TBI was recent or remote. However, in the hippocampus (B) and posterior
hypothalamic nucleus (E), a greater proportion of microglia colocalized with CD68 was only evident compared with naïves with a more recent TBI (see Table 5).
colocalize with CD68 puncta (Figure 7D). Rod microglia,
shown for the S1BF, aligned perpendicular to the dural surface
(Figure 7E). Microglia colocalized with CD68 were quantified
as the proportion of CD68+ microglia in relation to the
total number of microglia counted in the four images taken
of the S1BF, hippocampus, VPM, zona incerta, and posterior
hypothalamic nucleus (Figures 8A–E). Brain-injured groups had
significantly greater proportion of CD68+ microglia than naïve
(χ25 = 67.4; p < 0.001), but the proportion of CD68+ microglia
in age-at-injury groups varied significantly by region (χ220 =
106.1; p < 0.001) (see Supplementary Table 7 for estimated
counts and 95% CIs; Figures 8A–E). In the S1BF, VPM, and zona
incerta, brain-injured groups exhibited a significantly greater
proportion of CD68+ microglia compared with naïve (see
Table 5). However, in the hippocampus, only rats injured at 2-
and 4-months of age had a significantly greater proportion of
CD68+ microglia compared with naïve (see Table 5). In the
posterior hypothalamic nucleus, the only significant difference
was between rats brain-injured at 2-months of age compared
with naïve (see Table 5). These results indicate that microglia
colocalize with CD68 following a single diffuse brain injury,
which differs in extent between age-at-injury groups in the
hippocampus and posterior hypothalamic nucleus.
The Proportion of Microglia Colocalized
With TREM2 Was Greater in Brain-Injured
Groups in the S1BF, Regardless of Whether
the TBI Was Recent or Remote
Microglia express a range of cell surface receptors that detect
specific particulate in the extracellular space. Triggering receptor
expressed on myeloid cells 2 (TREM2) is a surface receptor
that detects damage-associated lipid patterns associated with
neurodegeneration (67, 68). Hence, dual immunohistochemical
analysis of TREM2 was conducted with Iba1 to examine whether
microglia may be utilizing this pathway to detect signals released
from pathological neurons in regions where neuropathology is
evident (S1BF, hippocampus) as well as connecting structures
(zona incerta, VPM, posterior hypothalamic nucleus). In the
S1BF, TREM2-positive (TREM2+) puncta were observed to
intermittently colocalize with microglia (Figures 9A–E). The
extent of TREM2 immunoreactivity by microglia was quantified
as the proportion of TREM2+ microglia in relation to the total
number of microglia counted in the four images taken in the
center of either the S1BF, hippocampus, VPM, zona incerta,
and posterior hypothalamic nucleus (Figures 10A–E). Brain-
injured groups had significantly greater proportion of TREM2+
microglia than naïve (χ25 = 21.1; p< 0.001), but the proportion of
TREM2+ microglia in age-at-injury groups varied significantly
by region (χ220 = 69.7; p < 0.001) (see Supplementary Table 8
for estimated counts and 95% CIs; Figures 10A–E). In the S1BF,
brain-injured groups exhibited a significantly greater proportion
of TREM2+ microglia compared with naïve (see Table 6).
However, in the hippocampus, only rats injured at PND17,
PND35, 2-, and 4-months of age showed a significantly greater
proportion of TREM2+microglia compared with naïve animals.
In the VPM, the only significant difference was between brain-
injured groups at 2-months of age compared with naïve (see
Table 6). Lastly, in the zona incerta and posterior hypothalamic
nucleus, the only significant difference was between groups
brain-injured at 4-months of age compared with naïve (see
Table 6). Hence, these results suggest that microglia colocalize
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TABLE 5 | CD68-positive microglia post-hoc contrasts between age-at-injury groups and naïve controls, separated by region, using the Dunnett’s procedure.
Contrast:
age-at-injury (Dunnett)
Region Co-efficient estimate Lower 95% CI Upper 95% CI p-Values
N vs. PND17 S1BF 1.1468 0.8194 1.474 <0.0001
N vs. PND35 S1BF 0.9006 0.5808 1.220 <0.0001
N vs. 2-months S1BF 1.1232 0.7917 1.455 <0.0001
N vs. 4-months S1BF 1.7312 1.4358 2.027 <0.0001
N vs. 6-months S1BF 1.7184 1.4241 2.013 <0.0001
N vs. PND17 Hippocampus 0.1959 −0.3804 0.772 0.5053
N vs. PND35 Hippocampus 0.0714 −0.4000 0.543 0.7666
N vs. 2-months Hippocampus 0.5103 0.0476 0.973 0.0306
N vs. 4-months Hippocampus 0.4599 0.0154 0.904 0.0426
N vs. 6-months Hippocampus 0.3571 −0.0962 0.810 0.1226
N vs. PND17 VPM 1.7736 1.0977 2.450 <0.0001
N vs. PND35 VPM 1.2096 0.5259 1.893 0.0005
N vs. 2-months VPM 1.4192 0.7234 2.115 0.0001
N vs. 4-months VPM 0.8476 0.1219 1.573 0.0221
N vs. 6-months VPM 1.4854 0.8377 2.133 <0.0001
N vs. PND17 Zona incerta 0.8935 0.2770 1.510 0.0045
N vs. PND35 Zona incerta 0.9005 0.3632 1.438 0.001
N vs. 2-months Zona incerta 1.3784 0.8365 1.920 <0.0001
N vs. 4-months Zona incerta 1.0947 0.5415 1.648 0.0001
N vs. 6-months Zona incerta 0.7951 0.2296 1.361 0.0059
N vs. PND17 Posterior hypothalamic
nucleus
0.4858 −0.1861 1.158 0.1564
N vs. PND35 Posterior hypothalamic
nucleus
−0.0364 −0.6937 0.621 0.9135
N vs. 2-months Posterior hypothalamic
nucleus
1.1304 0.5619 1.699 0.0001
N vs. 4-months Posterior hypothalamic
nucleus
−0.3006 −1.0716 0.470 0.4447
N vs. 6-months Posterior hypothalamic
nucleus
0.5068 −0.1058 1.119 0.1049
Bold means statistically significant p < 0.05.
with TREM2 after both recent and remote TBI in the S1BF, but
only after a recent brain injury in the VPM, zona incerta and
posterior hypothalamic nucleus. Hence, neuroinflammation is
determined by age-at-injury in specific brain regions.
DISCUSSION
Previously it was accepted that those living with TBI exhibit
fewer long-term symptoms if the brain injury event occurred at a
juvenile age than in adulthood and later-life (69). In fact, older
individuals are twice as likely to die from a brain injury than
children (69). More recent research suggests that individuals who
sustain a TBI in juvenile years will have different outcomes to
those who sustain a TBI when older (16, 25, 70). For example,
after a pediatric TBI, mice displayed social deficits in adulthood
(71). And yet, the underlying neuropathology and glial activation
across age-at-injury in relation to neurobehavioral function is
only recently investigated (72, 73). Past research has focused on
discrete time points post-injury rather than aging with injury.
This research was conducted as part of a larger behavior study
that subjected rats to diffuse brain injury at specific ages and
evaluated behavioral performance at a fixed age (28). The current
study aimed to determine whether the behavioral outcomes
mapped to neuropathology and glial activation. To investigate
neuropathological profiles, we evaluated APP, SMI34, SMI32, and
glial changes using GFAP and Iba1 in conjunction with CD68
and TREM2 at 10-months of age across age-at-injury compared
to naïve rats.
Overall, the results from this research demonstrate that there
was a greater extent of neuropathology and proportion of
microglial activation, but not astrogliosis, after a single diffuse
TBI compared with naïve, which depended on brain region.
Where the extent of neuropathology and proportion ofmicroglial
activation is similar in all brain-injured groups at 10-months
of age regardless of whether the TBI was recent or remote.
Amyloid precursor protein and SMI34 axonal pathology were
investigated in the CC and S1BF where the extent of pathology
was greater in all brain-injured groups when compared to naïve
and did not differ with age-at-injury. pTDP-43 neuropathology
was examined in the S1BF and hippocampus, where the extent
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FIGURE 9 | Examples of microglial morphologies in colocalization with TREM2 in the S1BF of rats brain-injured at 6-months of age. Representative images of
microglial morphologies were taken in the primary sensory barrel field (S1BF) of rats injured at 6-months of age; ramified (A), hyper-ramified (B), deramified (C),
amoeboid (D), and rod (E), and their colocalization with TREM2 indicated with the white arrows (scale bar = 50µm, inset = 10µm).
of pathology was greater in all brain-injured groups, regardless of
age-at-injury, compared with naïve. These findings indicate that a
brain-injury in early-life may harbor detectable neuropathology
in the gray and white matter that is equivalent to that observed
with a TBI in adulthood. The proportion of deramifiedmicroglial
morphologies, indicative of microglial activation, was also greater
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FIGURE 10 | The proportion of microglia colocalized with TREM2 were quantified in the S1BF, hippocampus, VPM, zona incerta, and posterior hypothalamic nucleus.
Microglial colocalization with TREM2 is expressed as the proportion of TREM2+ microglia (mean ± 95%CI) in the primary sensory barrel field (S1BF), hippocampus,
ventral posteromedial nucleus (VPM), zona incerta, and posterior hypothalamic nucleus. Significantly more TREM2+ microglia were observed following mFPI
compared to naïves in the S1BF (A), regardless of whether the TBI was recent or remote. However, in the hippocampus (B), a greater proportion of microglia
colocalized with TREM2 was only evident compared with naïves with a more remote TBI (see Table 14). This trend is the opposite in the zona incerta (C), VPM (D),
and posterior hypothalamic nucleus (E), where a greater proportion of microglia colocalized with TREM2 was only evident compared with naïves with a more recent
TBI (see Table 5).
after a TBI, irrespective of age-at-injury, in the S1BF and
hippocampus compared with naïve. However, this was not
observed in the connecting structures: VPM, zona incerta, and
posterior hypothalamic nucleus. Therefore, the proportion of
microglial activation is greater in brain-injured groups compared
with naïve in regions where neuropathology was also evident. As
we did not examine neuropathology in the connecting regions
it is unclear whether the lack of microglial activation in the
VPM, zona incerta, and posterior hypothalamic nucleus was a
result of neuropathological differences compared with the S1BF
and hippocampus. Therefore, sustaining a TBI as a juvenile
may hold a risk factor of neuropathology and microgliosis that
could affect the onset or magnitude of neurological diseases later
in life, such as dementia (74). A leading theory is that TBI
results in neuropathology similar to aging that includes APP,
neurofilament, and TDP-43 pathologies, as well as microglial
changes, which promote premature disease onset (75).
The amount of dendritic neuropathology and microglial
colocalization with functional markers depended on the whether
the TBI was recent or remote and was region-specific. SMI32
dendritic pathology was investigated in the CC and S1BF where
the extent of the pathology was greater in all brain-injured groups
compared with naïve in the white matter of the CC, regardless of
age-at-injury. However, there was only a greater extent of SMI32
pathology observed with more a recent brain-injury in the S1BF
comparedwith naïve. These results demonstrate that the extent of
neurofilament dendritic pathology is determined by age-at-injury
in the cortical gray matter after a TBI. This is in contrast to the
proportion of microglia colocalized with a surrogate marker of
phagocytosis (CD68) and alternative activation (TREM2) in the
S1BF, which was greater in all brain-injured groups compared
with naïve, regardless of whether the TBI was recent or remote.
Similar results were found for microglial colocalization with
CD68 in the VPM and zona incerta. The proportion of microglia
colocalized with CD68 and TREM2 was also determined by age-
at-injury in a region-specific manner. Only the more recent
TBI groups exhibited a greater proportion of CD68-positive
microglia compared with naïve in the hippocampus and posterior
hypothalamic nucleus. The groups with more remote brain-
injury had a greater proportion of microglia colocalized with
TREM2 in the hippocampus. However, this opposite trend was
observed in the VPM, zona incerta and posterior hypothalamic
nucleus, where the proportion of TREM2-positive microglia
was only greater than naïve with a recent TBI. Therefore, in
the hippocampus, microglia may exhibit a phagocytic role with
a recent TBI and possibly shift to an alternatively activated
phenotype as the TBI becomes more remote. While mFPI is not
associated with overt cell death, we have evidence from our silver
stain data that there is sub-acute neurodegeneration (33, 63).
The golgi stain in our rats also supports that there is change
in morphology of neurons that might require synaptic pruning
(63). Microglia may also be phagocytizing neuronal debris in
the aging brain as demonstrated in aged mice (76), thus, an
increase in microglial phagocytosis may reflect a normal part of
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TABLE 6 | TREM2-positive microglia post-hoc contrasts between age-at-injury groups and naïve controls, separated by region, using the Dunnett’s procedure.
Contrast:
age-at-injury (Dunnett)
Region Co-efficient estimate Lower 95% CI Upper 95% CI p-values
N vs. PND17 S1BF 2.3152 1.0349 3.600 0.0004
N vs. PND35 S1BF 1.9028 0.6177 3.190 0.0037
N vs. 2-months S1BF 1.3532 0.0630 2.640 0.0398
N vs. 4-months S1BF 1.6531 0.3400 2.970 0.0136
N vs. 6-months S1BF 1.4503 0.1296 2.770 0.0314
N vs. PND17 Hippocampus 2.0622 1.0298 3.090 0.0001
N vs. PND35 Hippocampus 1.6377 0.6015 2.670 0.0020
N vs. 2-months Hippocampus 1.7808 0.7321 2.830 0.0009
N vs. 4-months Hippocampus 1.1813 0.0763 2.290 0.0361
N vs. 6-months Hippocampus 0.8949 −0.2087 2.000 0.1120
N vs. PND17 VPM −0.1559 −1.4825 1.170 0.8178
N vs. PND35 VPM 0.2218 −1.0166 1.460 0.7255
N vs. 2-months VPM 1.3552 0.2834 2.430 0.0132
N vs. 4-months VPM 0.2021 −1.0377 1.440 0.7493
N vs. 6-months VPM 0.8558 −0.2397 1.950 0.1257
N vs. PND17 Zona incerta 1.8879 −0.2223 4.000 0.0795
N vs. PND35 Zona incerta 1.0958 −1.0898 3.280 0.3258
N vs. 2-months Zona incerta 1.4893 −0.6475 3.630 0.1719
N vs. 4-months Zona incerta 2.2212 0.1470 4.300 0.0358
N vs. 6-months Zona incerta 2.3050 0.2331 4.380 0.0292
N vs. PND17 Posterior hypothalamic
nucleus
0.0325 −1.7760 1.840 0.9719
N vs. PND35 Posterior hypothalamic
nucleus
1.1355 −0.4536 2.720 0.1614
N vs. 2-months Posterior hypothalamic
nucleus
1.1290 −0.4308 2.690 0.1560
N vs. 4-months Posterior hypothalamic
nucleus
2.0028 0.4730 3.530 0.0103
N vs. 6-months Posterior hypothalamic
nucleus
1.2118 −0.4207 2.840 0.1457
Bold means statistically significant p < 0.05.
the aging process. It is unclear as to whether the differences in the
microglial response between age-at-injury groups in connecting
brain structures, VPM, zona incerta, and posterior hypothalamic
nucleus, is a result of differences in neuropathology as this
was not investigated in these regions. Differential responses of
microglia phenotypes highlight the dynamic nature of microglial
activation after a TBI at various stages of development.
Astrocytes are also involved with inflammatory cascades,
alongside microglia, and form the glial scar around damaged
tissue to barricade the injured area and promote tissue repair
and resolution (77). Astrogliosis is typically reported to increase
after a TBI in post-mortem tissue and experimental models (78),
whilst in this study there were no significant differences in the
extent of astrogliosis post-injury in any of the ROIs, quantified
by the percentage of GFAP per mm2, compared to naïve or
between the different ages at which the injury occurred. Studies
in juvenile and young adult mice reported changes in astrocyte
processes up to 30-days after a juvenile-closed head injury and
moderate lateral FPI, respectively (79, 80). Specifically, after a
TBI in juvenile mice, astrocyte processes became longer and
thicker which initiated at the injury site and became evident
in connecting brain regions with time post-injury (80). After a
TBI in young adult mice, fewer astrocyte processes were directed
toward the granular cell layer of the hippocampus than astrocytes
of uninjured tissue. This study concluded that astrocytes alter
their morphology which may lead to detrimental changes to
astrocytic scaffolding of neurons. There was evidence of astrocyte
hypertrophy in this study, however, this was not specific to
injured animals and also occurred in naïve therefore, this may be
an artifact of the aging process as preciously described (81, 82).
A more detailed analysis of astrocyte morphology is required
to determine whether changes in the morphology of astrocytes
occurs with aging and after a TBI. As astrocyte activation did
not coincide with microglial activation, we hypothesize that
microglia can become activated independently of astrogliosis as
similar results have been reported in different brain regions of
mice 20-months after a CCI (83). However, we cannot determine
if one precedes or follows the other using the current study
design, this could only be achieved by including acute, sub-acute
and chronic timepoints post-injury.
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These immunohistochemical analyses were conducted as part
of a previously published behavior study (28). Chronic functional
outcomes of anxiety-like behavior and spatial memory were
examined at 8-, 9-, and 10-months of age. There were no
differences in ability for naïve and injured rats to walk around
the open field area, however, injured rats went into the center of
the arena fewer times than naïve. Brain-injured rats also spent less
time in the center of the arena compared with naïve, where brain-
injured groups at 2-, 4-, and 6-months spent the least amount of
time in the center of the arena. Brain-injured rats, particularly
those with a more recent injury, resided at the edges of the
open field arena at 8-months of age which is representative of
anxiety-like behavior (84). However, at 10-months of age there
were no differences in anxiety-like behavior detected using the
forced swim test, regardless of age-at-injury. Spatial memory was
assessed at 8-, 9-, and 10- months of age via the novel object
recognition test, although differences were observed at 8- and 9-
months of age by 10-months rats explored the novel object for a
similar time as naïve. These data suggest that by 10-months of age
spatial memory deficits had resolved regardless of age-at-injury.
However, the absence of functional deficits at 10-months of age
does not directly align with the histopathological findings of the
current study where neuropathology and microglial activation
are evident with differences observed between age-at-injury
groups. For example, spatial memory and anxiety are processed
within the hippocampus (85) and yet a greater extent of pTDP-
43 neuronal pathology and proportion of activated microglia
was observed in brain-injured hippocampus, regardless of age-at-
injury, at 10-months of age compared with naïve. The proportion
of microglia colocalized with TREM2 was also greater in the
hippocampus of brain-injured groups, particularly in those with
a remote TBI, compared with naïve. Therefore, the observed
pathological load may not reach a level of phenotypic expression
regarding the ability to perform the novel object recognition
and forced swim tests. Thus, more sensitive behavior tests may
be required, as clinically observations indicate lasting and often
subtle symptoms following a TBI that include depression as well
as memory and cognitive deficits (86–88).
At acute and chronic time points, the glial response was
associated exclusively with axonal degeneration in mice after a
lateral FPI in adolescence (1.5-months), adulthood (3-months),
and older age [12-months; (17)]. Furthermore, the axonal
degeneration was worse with increasing age-at-injury, suggesting
that the young brain can resolve neuropathology more effectively
(17). The discrepancy in the published and present results
may result from the use a more focal brain injury model
which includes contusion and primary mechanical injury that
is exacerbated with age-at-injury. The diffuse brain injury used
in the present research involves predominantly secondary injury
cascades which has been shown here to bemore prominent, long-
term, after a TBI in early-life compared to adulthood. The effect
of a secondary injury in adulthood after experiencing an initial
TBI as a juvenile has been examined in mice using the weight-
drop injury model (89). Mice injured as a juvenile (PND35)
exhibited improved pathological and functional outcomes after
a second brain-injury in adulthood (PND70), compared with
animals that received a single TBI at PND70 (89). The bone
structure of the skull directly above the injury site was observed
to have increased volume and resistance to torsion after a juvenile
TBI that further increased with time post-injury compared with
naïve mice (89). One interpretation of these results is that the
strengthening of the skull after a juvenile brain-injury protects
against further damage from a second injury in adulthood
and, thus, improves pathological and functional outcomes (89).
Therefore, a TBI in early-life may result in neuropathology
and microglial activation, as shown in this study, which could
increase the risk of developing age-related conditions. However,
an initial brain-injury as a juvenile may protect against further
damage from a secondary injury later in life as previously
described (89), though, further research is required to confirm
these results.
One of the major limitations of this study is the use of all
male rats. This study utilized a single cohort of animals (n =
81) in order to assure identical exposure to housing and seasonal
conditions. Therefore, all 81 male rats were processed at same
time and if we also included females, it would become practically
infeasible to process such a large number of animals. However,
there is increasing research demonstrating that there are sex
differences in behavioral and pathological outcomes after a TBI
in the clinic and laboratory (90–94). Research has shown that
males exhibit greater white matter damage than that observed
in females after a TBI using diffusion-tensor imaging (90). In
contrast to this, recent studies have demonstrated that females
showmore severe symptoms following TBI compared with males
(94). Further studies are required to examine the effect of age-at-
injury upon behavioral and pathological outcomes between sexes.
Another compromise of using a single cohort of animals in
this study was that pathology was not examined at multiple
time points post-injury, but only at 10-months. Since all animals
were euthanized at the same age, this raises the question of
whether changes to neuropathology and the glial response were
dependent upon age-at-injury or time-since-injury. Due to the
inability to distinguish between age-at-injury and time-since-
injury effects in this study, it is unclear whether temporal
pathogenesis changes with age-at-onset of injury. Looking
at other studies, it has been extensively documented that
neuropathology and glial activation is evident as early as 6-h
following a TBI (95). Yet, findings are controversial with time
post-injury, where neural and glial pathology has been reported
years post-injury in some studies (4). Whilst neuropathology
and gliosis have been observed to subside in the few weeks to
months following brain injury compared with higher levels at
acute time points (3, 96). Thus, these results indicate that there
are peaks and troughs in the extent of neuropathology and glial
activation with time following a TBI which we were not able
to examine using the current study design. Future experiments
could include the immunohistochemical markers used in this
study to elucidate how age-at-injury influences acute, sub-acute,
and chronic TBI-induced pathology.
We also need to explore neuropathology not just between
brain-injured and naïve animals, but also with other models of
disease. We know that neuronal and glial pathology observed
after a TBI is also evident in neurodegenerative diseases such as
Alzheimer’s disease, ALS, CTE (97–99). For example, amyloid
plaques, which are a hallmark pathological feature of AD, are
also evident in a subset of individuals following a TBI which
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are suggested to be derived from the accumulation of APP
in axons (100). Plaque deposition at 10-months of age in rat
models of amyloid pathology has been demonstrated to result
in loss of memory retention (101), which did was not evident
in the current study. Therefore, the extent of neuropathology
detected following a TBI in this study may not be enough to alter
functional outcomes observed in disease.We also need to explore
TBI-induced pathology in the context of aging. It has been
previously demonstrated that a TBI in aged rats (24-months old)
exhibit greater neuronal cell death than those injured as juveniles
(102). In addition, others have reported higher mortality and
greater neurological deficits at acute time points following TBI
in 20-month-old rats compared with those injured in adulthood
(69, 103). Therefore, in order to understand the burden of TBI-
induced pathology observed in this study, it is necessary to
compare the extent of pathology after a TBI to that observed with
age and in disease models.
Other areas of neuropathology to investigate between sexes,
with multiple time points post-injury compared with age and
disease models include changes to cell number and volume of
brain structures. Volumetric changes in the size of brain regions
such as the hippocampus, cerebral white matter, and lateral
ventricles have been identified at acute and sub-acute time points
after a TBI in humans and in rodent focal injury models using
magnetic resonance imaging (MRI) which are demonstrated to
be a predictor of functional outcomes (104, 105). However,
limited studies have investigated the volume of brain structures
following diffuse brain injury in rats (106, 107) and at chronic
time points following injury. Changes to cell number has also
not yet been explored at chronic time points post-injury but
acutely and sub-acutely we have data to support that there is an
increase in the number of microglia and a decrease of neurons
in the cortex of rodents using this injury model (33, 108).
Unfortunately, the processes used to collect the tissue for the
current paper prevented volumetric analysis and stereological
cell counts. Additionally, a more in-depth glial analysis looking
at morphological changes of astrocytes and microglia would be
valuable in order to create a more complete picture of TBI
pathophysiology with respect to the age at which injury occurred.
CONCLUSION
In conclusion, the results from this study further the notion
that age-at-injury plays a role in the extent of neuropathology
after a TBI. Effective treatment strategies and prediction of long-
term outcomes after a brain-injury will need to consider the
age at which the injury occurred. This study examines aging
with a brain injury via immunohistochemistry which was part
of a broader study investigating the effects of age-at-injury on
behavioral performance across time post-injury. Although no
behavioral phenotype was evident in brain-injured rats at 10-
months of age compared with naïve, there was a greater extent of
neuropathology and proportion of activatedmicroglia, regardless
of whether the TBI was recent or remote. In addition to this,
the extent of dendritic neurofilament pathology, and proportion
of microglial colocalization with functional markers after a TBI
was determined by age-at-injury in a region-specific manner.
The distinct pattern of pathological features after a brain-injury
at discrete stages of development may influence the risk of
developing neurodegenerative diseases in later life. Additional
research is recommended to distinguish between the effects of
age-at-injury and time-since-injury as well as explore possible
sex differences.
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